| Affiliation: | (1) Department of Disease Glycomics (Seikagaku Corporation), The Institute of Scientific and Industrial Research, Osaka University, 8–1 Mihogaoka, Ibaraki Osaka, 567-0047, Japan;(2) Laboratory of Biochemistry, School of Pharmacy, Hyogo University of Health Sciences, 1-3-6 Minatojima, Chuo-ku, Kobe Hyogo, 650-8530, Japan;(3) Systems Glycobiology Research Group, Chemical Biology Department, Advanced Science Institute, RIKEN, 2-1 Hirosawa, Wako Saitama, 351-0198, Japan;(4) Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-2 Nakamichi, Higashinari-ku Osaka, 537-8511, Japan;(5) Department of Pharmacology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku Chiba, 260-8670, Japan;(6) Department of Biochemistry, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo, 663-8501, Japan;(7) Department of Disease Glycomics (Seikagaku Corporation), The Institute of Scientific and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibaraki Osaka, 567-0047, Japan;(8) Systems Glycobiology Research Group, Chemical Biology Department, Advanced Science Institute, RIKEN, 2-1 Hirosawa, Wako Saitama, 351-0198, Japan;(9) Laboratory of Biochemistry, School of Pharmacy, Hyogo University of Health Sciences, 1-3-6 Minatojima, Chuo-ku, Kobe Hyogo, 650-8530, Japan |
